QNTM
Quantum BioPharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$2.41
−2.43%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.50
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.47
- EPS estimate
- -$0.41
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -258.2%
- Revenue beats (12Q)
- 0
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.41 | -$0.47 | Miss -14.19% | — |
| May 7, 2026 | -$0.49 | -$3.06 | Miss -524.01% | — |
| Mar 26, 2026 | -$1.02 | -$0.71 | Beat 30.49% | — |
| Nov 7, 2025 | -$0.20 | -$1.25 | Miss -525.00% | — |
| May 14, 2025 | -$0.37 | -$1.41 | Miss -281.08% | $2.2M |
| Mar 28, 2025 | -$0.80 | -$2.89 | Miss -261.25% | — |
| Aug 14, 2024 | -$3.90 | -$5.20 | Miss -33.33% | — |
| Nov 15, 2023 | -$9.09 | -$1.95 | Beat 78.53% | — |
| Jul 20, 2023 | — | -$9.31 | — | — |
| Nov 15, 2021 | — | -$9.57 | — | — |
| Aug 12, 2021 | — | -$23 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026